Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
Recruiting
Observational Study
Pneumonia
Fungal Pneumonia
Aspergillosis Pneumonia
Pulmonary Aspergillosis
Pulmonary Aspergillosis Invasive
Pneumocystis
Pneumocystis Pneumonia
Fungal Disease
Fungal Infection
Fungal Infection Lungs
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The FUNGAL-P study is a single-center observational study designed to derive and validate a clinical prediction score for the early identification of fungal pneumonia in adult patients presenting with pneumonia.
The study includes a retrospective derivation cohort and a prospective validation cohort of patients undergoing microbiological evaluation of lower respiratory tract samples. Clinical, la…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years and ≤90 years.
* Presentation to the Emergency Department or hospital with pneumonia.
* Pneumonia defined according to IDSA/ATS criteria as the presence of at least two clinical signs or symptoms of lower respiratory tract infection (temperature \<36.0°C or \>38.…
Contacts